Effect of Hebal and Synthetic Medicamentss on Enterococcus Feacalis

Sponsor
Tanta University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06006663
Collaborator
(none)
32
4
3.5

Study Details

Study Description

Brief Summary

this study aims to evaluate the antimicrobial efficacy of two synthetic (Ibuprofen, Modified triple antibiotic paste) and two herbal materials (Curcumin and Olive leaves extract) used as intracanal medication, against E.Faecalis in secondary endodontic infection cases.

Condition or Disease Intervention/Treatment Phase
  • Drug: Ibuprofen 400 mg.
  • Drug: modified triple antibiotic paste
  • Dietary Supplement: curcumin
  • Dietary Supplement: olive leaves extract
Phase 2/Phase 3

Detailed Description

we evaluate the antimicrobial efficacy of two synthetic (Ibuprofen, Modified triple antibiotic paste) and two herbal materials (Curcumin and Olive leaves extract) used as intracanal medication, against E.Faecalis in secondary endodontic infection cases by taking three samples from root canal , the first sample after removing gutta percha from root canal system, the second sample after shaping with protaper universal files and cleaning with 2.5% sodium hypochlorite , the third sample after 7 days from application of the medication .

samples will be diluted into ten fold serial dilution and then the diluted samples will be cultured on bile esculin agar as it is selective media for enterococcus feacalis.

bacterial reduction will be determined and comparision will be made .

Study Design

Study Type:
Interventional
Anticipated Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Antimicrobial Efficacy of Synthetic Versus Herbal Intracanal Medicaments Against Enterococcus Faecalis
Anticipated Study Start Date :
Aug 26, 2023
Anticipated Primary Completion Date :
Oct 5, 2023
Anticipated Study Completion Date :
Dec 10, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: group 1

ibuprofen as intracanal medicament

Drug: Ibuprofen 400 mg.
synthetic intracanal medicament

Active Comparator: group 2

modified triple antibiotic paste as intracanal medicament

Drug: modified triple antibiotic paste
synthetic intracanal medicament
Other Names:
  • clindamycin, ciprofloxacin and metronidazole
  • Active Comparator: group 3

    curcumin as intracanal medicament

    Dietary Supplement: curcumin
    herbal intracanal medicament

    Active Comparator: group 4

    olive leaves as intracanal medicament

    Dietary Supplement: olive leaves extract
    herbal intracanal medicament

    Outcome Measures

    Primary Outcome Measures

    1. measurment of microbial reduction as result of applying synthetic and herbaal intracanal medicaments [time necessary for incubation of each sample is 24 hour]

      sample 1 will be taken after gutta percha removal sample 2 will be taken after cleaning and shaping sample 3 will be taken after apllying the intracanal medicament for one week

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Single rooted teeth.

    • Teeth have clinical signs and symptoms of endodontic failure as sensitivity to percussion, pain, swelling or fistula.

    • Teeth with radiographic features of endodontic failure as persistent periapical lesion or widening of periodontal ligament.

    Exclusion Criteria:
    • • Teeth with fractures of the crown or root.

    • Teeth with periodontal pocket deeper than 4mm.

    • Teeth have procedural error like ledge, broken instrument, or perforation.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Tanta University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alaa Essam Ahmed Abo Laimon, Demonstrator , Endodontic department,Faculty of dentistry,Tanta university, Tanta University
    ClinicalTrials.gov Identifier:
    NCT06006663
    Other Study ID Numbers:
    • eliminations of E.faecalis
    First Posted:
    Aug 23, 2023
    Last Update Posted:
    Aug 23, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 23, 2023